Aevi Genomic Medicine, Inc. Share-based Payment Arrangement, Expense
Aevi Genomic Medicine, Inc. reported Share-based Payment Arrangement, Expense of $9.19 million for the 12-month period ending 2015-12-31, per its 10-K filed 2016-02-26.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2016-02-26
- Aevi Genomic Medicine, Inc. share-based payment arrangement, expense for the quarter ending 2015-12-31 was $1.55M, a 17.51% increase year-over-year.
- Aevi Genomic Medicine, Inc. share-based payment arrangement, expense for the quarter ending 2015-09-30 was $1.80M, a 32.11% increase year-over-year.
- Aevi Genomic Medicine, Inc. share-based payment arrangement, expense for the quarter ending 2015-06-30 was $2.72M, a 54.89% increase year-over-year.
- Aevi Genomic Medicine, Inc. share-based payment arrangement, expense for the quarter ending 2015-03-31 was $3.12M, a 76.70% increase year-over-year.
- Aevi Genomic Medicine, Inc. share-based payment arrangement, expense for fiscal 2015 was $9.19M, a 48.15% increase from fiscal 2014.
- Aevi Genomic Medicine, Inc. share-based payment arrangement, expense for fiscal 2014 was $6.20M, a 29.64% increase from fiscal 2013.
- Aevi Genomic Medicine, Inc. share-based payment arrangement, expense for fiscal 2013 was $4.78M, a 59.10% increase from fiscal 2012.
- Aevi Genomic Medicine, Inc. share-based payment arrangement, expense for fiscal 2012 was $3.01M.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2015-12-31 | $1.55M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $3.35M derived: sum of 2 quarters · filed 2016-02-26 | $6.07M derived: sum of 3 quarters · filed 2016-02-26 | $9.19M 10-K · filed 2016-02-26 |
| 2015-09-30 | $1.80M 10-Q · filed 2015-10-22 | $4.52M derived: sum of 2 quarters · filed 2015-10-22 | $7.64M 10-Q · filed 2015-10-22 | $8.96M derived: sum of 4 quarters · filed 2016-02-26 |
| 2015-06-30 | $2.72M 10-Q · filed 2015-08-10 | $5.84M 10-Q · filed 2015-08-10 | $7.16M derived: sum of 3 quarters · filed 2016-02-26 | $8.52M derived: sum of 4 quarters · filed 2016-02-26 |
| 2015-03-31 | $3.12M 10-Q · filed 2015-04-20 | $4.44M derived: sum of 2 quarters · filed 2016-02-26 | $5.80M derived: sum of 3 quarters · filed 2016-02-26 | $7.55M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-12-31 | $1.32M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $2.68M derived: sum of 2 quarters · filed 2016-02-26 | $4.44M derived: sum of 3 quarters · filed 2016-02-26 | $6.20M 10-K · filed 2016-02-26 |
| 2014-09-30 | $1.36M 10-Q · filed 2015-10-22 | $3.12M derived: sum of 2 quarters · filed 2015-10-22 | $4.88M 10-Q · filed 2015-10-22 | $6.57M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-06-30 | $1.76M 10-Q · filed 2015-08-10 | $3.52M 10-Q · filed 2015-08-10 | $5.21M derived: sum of 3 quarters · filed 2016-02-26 | $6.23M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-03-31 | $1.76M 10-Q · filed 2015-04-20 | $3.45M derived: sum of 2 quarters · filed 2016-02-26 | $4.47M derived: sum of 3 quarters · filed 2016-02-26 | $5.09M derived: sum of 4 quarters · filed 2016-02-26 |
| 2013-12-31 | $1.68M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $2.71M derived: sum of 2 quarters · filed 2016-02-26 | $3.33M derived: sum of 3 quarters · filed 2016-02-26 | $4.78M 10-K · filed 2016-02-26 |
| 2013-09-30 | $1.02M 10-Q · filed 2014-10-15 | $1.65M derived: sum of 2 quarters · filed 2014-10-15 | $3.10M 10-Q · filed 2014-10-15 | |
| 2013-06-30 | $622.00K 10-Q · filed 2014-07-16 | $2.08M 10-Q · filed 2014-07-16 | ||
| 2012-12-31 | $3.01M 10-K · filed 2015-02-13 |